Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sally, Prüschenk"'
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 9837 (2023)
The inositol triphosphate-associated proteins IRAG1 and IRAG2 are cGMP kinase substrate proteins that regulate intracellular Ca2+. Previously, IRAG1 was discovered as a 125 kDa membrane protein at the endoplasmic reticulum, which is associated with t
Externí odkaz:
https://doaj.org/article/378a4f1721db447e8752cb829484975e
Autor:
Sally Prüschenk, Jens Schlossmann
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6695 (2022)
Inositol 1,4,5-triphosphate receptor-associated 2 (IRAG2) is a type II membrane protein located at the endoplasmic reticulum. It is a homologue of inositol 1,4,5-triphosphate receptor-associated cGMP kinase substrate 1 (IRAG1), a substrate protein of
Externí odkaz:
https://doaj.org/article/01492df3947e44e3837f4b40947677d0
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 24, p 13409 (2021)
The inositol 1,4,5-triphosphate receptor-associated 2 (IRAG2) is also known as Jaw1 or lymphoid-restricted membrane protein (LRMP) and shares homology with the inositol 1,4,5-triphosphate receptor-associated cGMP kinase substrate 1 (IRAG1). IRAG1 int
Externí odkaz:
https://doaj.org/article/3a429ec761f048f2b90c641a5d71f298
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13409, p 13409 (2021)
International Journal of Molecular Sciences; Volume 22; Issue 24; Pages: 13409
International Journal of Molecular Sciences; Volume 22; Issue 24; Pages: 13409
The inositol 1,4,5-triphosphate receptor-associated 2 (IRAG2) is also known as Jaw1 or lymphoid-restricted membrane protein (LRMP) and shares homology with the inositol 1,4,5-triphosphate receptor-associated cGMP kinase substrate 1 (IRAG1). IRAG1 int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a3337ce4282087705facb083fa2630
https://epub.uni-regensburg.de/52039/
https://epub.uni-regensburg.de/52039/
Diabetic nephropathy is the leading cause for end-stage renal disease worldwide. Until now, there is no specific therapy available. Standard treatment with inhibitors of the renin-angiotensin system just slows down progression. However, targeting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9c0074d9b3328db23fc2e43875cac47
https://epub.uni-regensburg.de/47906/
https://epub.uni-regensburg.de/47906/